Reviv3 Procare Company
RVIV · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | – | $0 | $5 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | – | $0 | $0 |
| Gross Profit | $5 | – | $5 | $5 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $3 | – | $3 | $4 |
| Sales & Mktg Exp. | $3 | – | $3 | $3 |
| Other Operating Expenses | $0 | – | $1 | $1 |
| Operating Expenses | $3 | – | $4 | $5 |
| Operating Income | $1 | – | $1 | $1 |
| % Margin | – | – | – | 12.2% |
| Other Income/Exp. Net | $0 | – | $0 | $0 |
| Pre-Tax Income | $0 | – | $1 | $1 |
| Tax Expense | $0 | – | $0 | $0 |
| Net Income | $0 | – | $1 | $1 |
| % Margin | – | – | – | 11.5% |
| EPS | 0 | – | 0.09 | 0.098 |
| % Growth | – | – | -8.4% | – |
| EPS Diluted | 0 | – | 0.07 | 0.059 |
| Weighted Avg Shares Out | 0 | – | 7 | 6 |
| Weighted Avg Shares Out Dil | 0 | – | 8 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $0 | $0 |
| Interest Expense | $0 | – | $0 | -$0 |
| Depreciation & Amortization | $0 | – | $0 | $0 |
| EBITDA | $0 | – | $1 | $1 |
| % Margin | – | – | – | 12.2% |